A Global Survey of Potential Acceptance of a COVID-19 Vaccine
By: Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball & Ayman El-Mohandes
Source: Nature
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.
VARN2022: Shaping Global Vaccine Acceptance with Localized [Peer-Reviewed] Knowledge
Some of the most relevant findings are now available through the VARN2022 Supplement via BMC Proceedings...
Community-led Strategies to Aid Vaccine Acceptance: Nine Case Studies from Around the World
These case-study reports inform action and investment around the globe that seek to build more vaccine confident communities.
Video Narrative Project
Sabin’s Social and Behavioral Research Grant Partners, over the course of a year, explored the local barriers and enablers of vaccination acceptance,
Health for All Ages: Life-course immunization
The benefits of a life-course immunization approach for reaching zero dose-adults, children, and promoting vaccine equity worldwide.
